Position in KRYS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$286,218
+$286,218 QoQ
Shares Held
1,108
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in KRYS
reported options exposure · as of Mar 31, 2024CallValue
$533,790
CallShares
3,000
PutValue
$391,446
PutShares
2,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,164 | $1,079,924 | |
| 2 | GMAB |
Genmab A/S
|
32,116 | $882,226 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,452 | $437,095 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
25,320 | $430,440 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
35,537 | $409,741 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 | |
| 8 | BHVN |
Biohaven Ltd.
|
16,988 | $252,781 |
All Filings in KRYS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $286,218 | 1,108 | Shares | Defined | 2026-05-15 | |
| 2024-03-31 | $533,790 | 3,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $391,446 | 2,200 | Put | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||